e Brucella spp. are facultative intracellular Gram-negative coccobacilli responsible for brucellosis, a worldwide zoonosis. We observed that Brucella melitensis is able to persist for several weeks in the blood of intraperitoneally infected mice and that transferred blood at any time point tested is able to induce infection in naive recipient mice. Bacterial persistence in the blood is dramatically impaired by specific antibodies induced following Brucella vaccination. In contrast to Bartonella, the type IV secretion system and flagellar expression are not critically required for the persistence of Brucella in blood. ImageStream analysis of blood cells showed that following a brief extracellular phase, Brucella is associated mainly with the erythrocytes. Examination by confocal microscopy and transmission electron microscopy formally demonstrated that B. melitensis is able to invade erythrocytes in vivo.
Brucella is a facultative intracellular alphaproteobacterium that causes abortion and infertility in mammals and leads to a debilitating febrile illness in humans. Although it is rarely fatal, human brucellosis can progress into a severe chronic disease if left untreated (1, 2). Despite significant progress, the incidence of human brucellosis remains very high in areas of endemicity (3). Complete eradication of Brucella would be impractical due to its presence in a large range of wild mammals (4, 5). Moreover, antibiotic treatment is costly, and patients frequently suffer from relapse of the illness (6, 7). Vaccination actually remains the only rational strategy to confer protection on populations living in countries of endemicity. Unfortunately, there is currently no available vaccine against human brucellosis, since all commercial animal vaccines are based on live attenuated strains of Brucella (8) that are still virulent in humans. Efforts to develop an effective vaccine are impaired by our poor knowledge of the Brucella life cycle in vivo and of the protective immune response induced by infection. In particular, the mechanisms of early Brucella dissemination in vivo remain largely unknown. A prominent characteristic of brucellosis is its long incubation period. The current hypothesis is that this period, corresponding to reduced activation of innate immunity, opens an "immunological window" and gives Brucella the chance to spread throughout the organism to establish a replication niche within phagocytic cells (9).Bacteremia is one major characteristic of human brucellosis (10) and is often associated with an increased risk of relapse (6, 11). Moreover, positive blood cultures are synonymous with secondary seeding and development of focal complications of the disease. Bacteremia in mice infected by intraperitoneal injection, the most frequent route of experimental infection, has been reported in some studies (12, 13). However, to our knowledge, the mechanism of Brucella persistence in the blood has never been investigated. In this study, we monitored bacteremia in mice for several weeks after the intraperito...